全部文献期刊学位论文会议报纸专利标准年鉴图书|学者科研项目
中外文文献  中文文献  外文文献
作者:... Chen D , Chen Z , Shen S
来源:[J].OncoTargets and Therapy(IF 2.073), 2019, Vol.Volume 12, pp.4081-4092DOAJ
摘要:Zi Ye,1 Zhirui Zeng,2,3 Yiyi Shen,4 Qiang Yang,1 Duidui Chen,1 Zubing Chen,1 Shiqiang Shen11Department of General Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, People’s Republic of China; 2Guizhou Provincial Key Laboratory of Pathogenesis & Drug Research...
作者:Shen S , Yan Z ...
来源:[J].OncoTargets and Therapy(IF 2.073), 2019, Vol.Volume 12, pp.4181-4193DOAJ
摘要:Cunyi Zou,1,* Chen Zhu,1,* Gefei Guan,1 Qing Guo,1 Tianqi Liu,1 Shuai Shen,1 Zihao Yan,1 Xiaoyan Xu,2 Zhiguo Lin,3 Ling Chen,4 Anhua Wu,1 Wen Cheng11Department of Neurosurgery, The First Hospital of China Medical University, Shenyang, Liaoning 110001, People’s Republic of Ch...
作者:... Sun R , Shen S , Yu Z
来源:[J].OncoTargets and Therapy(IF 2.073), 2016, Vol.2016 (Issue 1), pp.615-616DOAJ
摘要:Gu J, Sun R, Shen S, Yu Z. The influence of TLR4 agonist lipopolysaccharides on hepatocellular carcinoma cells and the feasibility of its application in treating liver cancer. Onco Targets Ther. 2015;8:2215–2225.The first author (Junsheng Gu) created an email address for Dr ...
作者:... Sun R , Shen S , Yu Z
来源:[J].OncoTargets and Therapy(IF 2.073), 2015, Vol.2015 (default), pp.2215-2225DOAJ
摘要:Junsheng Gu, Ranran Sun, Shen Shen, Zujiang Yu Department of Infectious Diseases, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, People’s Republic of China Objective: This study was designed to explore the influence of Toll-like receptor 4 (TLR4) agon...
作者:Shen S , Gu L
来源:[J].Patient Preference and Adherence(IF 1.333), 2015, Vol.2015 (default), pp.1165-1169DOAJ
摘要:Yingjia Sun, Xinghao Ai, Shengping Shen, Linping Gu, Shun Lu Lung Tumor Clinical Medical Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People’s Republic of China Objective: To detect and analyze 13 cytokines that may be related to bone metastasis ...
作者:Shen S , Jia H ...
来源:[J].Cancer Management and Research, 2019, Vol.Volume 11, pp.4607-4615DOAJ
摘要:Yue Hu,1,2,* Jingsi Mei,1,2,* Xiaofang Jiang,1,2 Ran Gu,1,2 Fengtao Liu,1,2 Yaping Yang,1,2 Hongli Wang,1,2 Shiyu Shen,1,2 Haixia Jia,3 Qiang Liu,1,2 Chang Gong1,21Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation; 2Breast Tumor Center, S...
作者:Shen S , Shi W ...
来源:[J].Cancer Management and Research, 2019, Vol.Volume 11, pp.6543-6552DOAJ
摘要:Zhiwei Chen,1,* Shengping Shen,1,* Wenbo Shi,1,* Gening Jiang,2 Xin Wang,3 Hong Jian,1 Zhen Zhou,1 Zhengping Ding,1 Shun Lu11Tumor Clinical Medical Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, People’s Republic of China; 2Department of Tho...
作者:Shen S , Xu G ...
来源:[J].Cell death & disease(IF 6.044), 2016, Vol.7, pp.e2106PubMed
摘要:Cucurbitacin-I (Cu-I, also known as Elatericin B or JSI-124) is developed to inhibit constitutive and abnormal activation of STAT3 in many cancers, demonstrating a potent anticancer activity by targeting disruption of STAT3 function. Here, we for the first time systematicall...
作者:Shen S , Jejah I A
来源:[J].Singapore medical journal(IF 0.63), 2015, Vol.56 (3), pp.e36-8PubMed
摘要:Herein, we report another case of arteritic anterior ischaemic optic neuropathy from Singapore, in which the initial optic disc swelling was extreme and the sequential disease resolved because the patient was already on maximum treatment. As the management of this biopsy-proven g...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×